Artelo Biosciences (ARTL) Return on Equity [ROE] (2015 - 2025)
Artelo Biosciences (ARTL) posted Return on Equity [ROE] of -1463.47% for FY2025, down 1325.09 percentage points from -138.38% in FY2024.
Powered by 
Analysis
Artelo Biosciences (ARTL) Return on Equity [ROE] (2015 - 2025) Analysis & Trends
Since FY2015, Artelo Biosciences has reported Return on Equity [ROE] for 11 years.
- Annual Return on Equity [ROE] has declined for three consecutive years, with a five-year change of -1363.10 percentage points (FY2020 to FY2025).
- The FY2025 figure stands as the lowest annual Return on Equity [ROE] since FY2016.
- Business Quant data shows ARTL's Return on Equity [ROE] at -138.38% in FY2024 (-74.63 pp), -63.75% in FY2023 (-19.55 pp), -44.19% in FY2022 (+3.83 pp) and -48.02% in FY2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 82.09% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 25.32% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 7.21% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 84.40% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 21.39% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 83.75% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -18.38% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.97% |
| 10 | Artelo Biosciences | 73,320.32 | -5.06 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | -563.75% |
| Dec 31, 2024 | -219.31% |
| Sep 30, 2024 | -139.62% |
| Jun 30, 2024 | -130.14% |
| Mar 31, 2024 | -96.08% |
| Dec 31, 2023 | -75.43% |
| Sep 30, 2023 | -65.91% |
| Jun 30, 2023 | -58.70% |
| Mar 31, 2023 | -57.43% |
| Dec 31, 2022 | -49.82% |
| Sep 30, 2022 | -40.95% |
| Jun 30, 2022 | -37.15% |
| Mar 31, 2022 | -31.86% |
| Nov 30, 2021 | -40.19% |
| May 31, 2021 | -53.13% |
| Feb 28, 2021 | -48.21% |
| Nov 30, 2020 | -74.01% |
| Aug 31, 2020 | -131.99% |
| May 31, 2020 | -133.02% |
| Feb 29, 2020 | -106.13% |
API Access
Artelo Biosciences Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();